NeuroSense Therapeutics CFO Or Eisenberg will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York City. He will hold meetings with institutional investors to discuss the company's recent clinical and regulatory progress with PrimeC, their lead drug candidate for treating amyotrophic lateral sclerosis (ALS). NeuroSense recently published positive Phase 2b trial results showing PrimeC slows ALS progression and has FDA clearance to start a pivotal Phase 3 trial. The company aims to advance PrimeC toward regulatory approval in the U.S., Canada, and other key markets.
NeuroSense's upcoming participation in the 5th Annual ROTH Healthcare Opportunities Conference provides context for health sector activity. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 28, 2026 23:41 WIB: Among 100 priced US health-sector stocks tradable on Pluang, 53 rose and 47 fell today. Notable movers include ISRG (Intuitive Surgical, Inc.) at USD 415.01 with a +2.43% change and a typical hold time of 85 days, BNGO (BioNano Genomics Inc) at USD 1.70 with a +2.41% change and a 49-day hold time, and CRON (Cronos Group Inc) at USD 3.42 with a +2.40% change and a 22-day hold time.
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...
Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...
Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...
JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...
